
Similar Posts
FIGO: committed to protect and promote girls and young women SRHR
October 2021. The International Federation of Gynecology and Obstetrics (FIGO) calls on its members to commit to discussing sexual and reproductive health, including contraception, infection prevention and safe sex, in their conversations with young people, girls, and boys. Around the world, complications during pregnancy and childbirth are the leading cause of death for 15–19-year-old girls….
Russian Federation: Mifepristone EC pills less accessible
March 2025. Emergency contraceptive (EC) pills with a low dose of mifepristone (10 to 25 mg), have been available in a few countries for many years, including Armenia, Russia, China, Moldova, Ukraine and Vietnam. In 2023, however, the Ministry of Health of the Russian Federation approved a list of drugs and active ingredients that are…
EMA recommends double dose of LNG EC when used with enzyme-inducers
On May 2016, the European Medicines Agency (EMA) recommended the use of a non-hormonal emergency contraceptive (EC) when a woman in need of EC is using other interacting medicines (such as the HIV medicine efavirenz and ritonavir, certain medicines for tuberculosis and epilepsy, and herbal medicines containing St John’s wort). If using a cooper IUD…
Contraception Atlas 2018
April 11, 2018. The European Parliamentary Forum on Population & Development (EPF) launches the Contraception Atlas 2018. In this second edition, the Atlas tracks government policies on a) access to contraceptive methods, b) family planning counselling and c) provision of online information on contraception, in 46 European states. Belgium, France and the United Kingdom rank…
Youth and EC
June 2020. ECEC participated in the webinar organised by FP2020 “Emergency contraception and young people. Your questions answered” on June 16th. These are some of the issues addressed: What are the facts about young people’s use of EC? Does it match our assumptions? Is it safe for young people to use EC frequently? How frequent…
European Commission decision grants 120 million women direct access to ellaOne®
HRA Pharma announced that the European Commission, in a historic ruling, has authorized the emergency contraceptive ellaOne® to be accessible directly from pharmacies without the need for a prescription from a doctor. This is the first ever decision of its type regarding any oral contraceptive product applicable to all EU member states, according to national…
